Rejuvenation Research

《返老还童研究》（Rejuvenation Research，常用缩写 Rejuvenation Res.）是聚焦衰老与年轻化干预的同行评议期刊，前身为 1998 年创刊的《抗衰老医学杂志》（Journal of Anti-Aging Medicine），2004 年改为现名，原由玛丽·安·利伯特出版，2025 年起转由 SAGE 出版，每年 6 期，2025 年影响因子 1.8。Rejuvenation Research (commonly abbreviated Rejuvenation Res.) is a peer-reviewed journal focused on ageing and rejuvenation interventions, succeeding the Journal of Anti-Aging Medicine founded in 1998 and renamed to its current title in 2004, originally published by Mary Ann Liebert and transferred to SAGE in 2025, issued six times a year, with a 2025 impact factor of 1.8.

Scope

刊物官方宗旨为发表延缓或逆转衰老过程的前沿研究，官方声明的征稿范围包括：The journal's stated aim is to publish cutting-edge research on slowing or reversing the ageing process, with its official scope covering:

• 衰老与年轻化机制： 心血管衰老、DNA 损伤与修复、细胞衰老与永生化、克隆与干细胞、端粒生物学与衰老相关信号通路的基础与转化研究。Mechanisms of ageing and rejuvenation: basic and translational studies on cardiovascular ageing, DNA damage and repair, cellular senescence and immortalisation, cloning and stem cells, telomere biology and ageing-related signalling pathways.
• 干预与治疗： 可能减缓或逆转衰老进程的实验与临床干预，包括药物、基因治疗、细胞治疗与生活方式干预的研究。Interventions and therapeutics: experimental and clinical interventions that may slow or reverse the ageing process, including pharmaceuticals, gene therapy, cell therapy and lifestyle interventions.
• 栏目设置： 接受原创研究论文、综述、社论、评论与生物技术新闻，亦发表该领域的高影响力创新研究与文献综述。Article types: original research papers, reviews, editorials, commentaries and biotechnology news, together with high-impact innovative studies and comprehensive literature reviews in the field.

History

• 刊名沿革： 1998 年以《抗衰老医学杂志》（Journal of Anti-Aging Medicine）创刊，主编为迈克尔·福塞尔（Michael Fossel），2004 年第 7 卷第 1 期更名为《返老还童研究》。Title history: founded in 1998 as the Journal of Anti-Aging Medicine with Michael Fossel as editor-in-chief, and renamed Rejuvenation Research from volume 7, issue 1 in 2004.
• 出版方变迁： 2004 年至 2024 年间由美国纽约州新罗谢尔的玛丽·安·利伯特公司出版，2025 年第 28 卷起转由 SAGE 出版。Publisher change: published by Mary Ann Liebert, Inc. in New Rochelle, New York, from 2004 to 2024, and transferred to SAGE from volume 28 in 2025.
• 出版频率： 早期为季刊，后改为每年 6 期的双月刊，现每年出版 6 期。Publication frequency: originally quarterly, later changed to six issues per year as a bimonthly journal, and currently publishes six issues per year.
• 指标走势： 影响因子在 2017 至 2021 年间为 3.2 至 4.7，2022 年为 2.6，2023 年为 2.2，2024 年为 2.6，2025 年回落至 1.8，2025 年 JCR 老年医学分区为四区。Metric trend: the impact factor ranged from 3.2 to 4.7 between 2017 and 2021, stood at 2.6 in 2022, 2.2 in 2023, 2.6 in 2024 and fell to 1.8 in 2025, placing it in the fourth quartile of geriatrics and gerontology in the 2025 JCR.

Editors

编辑部由联合主编、副编辑与编委会组成，成员来自衰老生物学与老年医学领域：The editorial office comprises co-editors-in-chief, associate editors and an editorial board, drawn from the biology of ageing and geriatrics:

• 联合主编： 伊琳娜·康博伊（Irina Conboy），美国加州大学伯克利分校生物工程系教授，研究方向为通过血液循环因子调控组织衰老与再生。Co-editor-in-chief: Irina Conboy, professor in the Department of Bioengineering at the University of California, Berkeley, whose research focuses on the regulation of tissue ageing and regeneration by circulating blood factors.
• 副编辑团队： 副编辑覆盖干细胞、DNA 修复、细胞衰老、端粒生物学与老年医学等方向，协助处理稿件。Associate editors: covering stem cells, DNA repair, cellular senescence, telomere biology and geriatrics, supporting manuscript handling.
• 开放获取： 刊物为混合开放获取，作者可选择订阅模式或付费开放获取发表，2025 年金色开放获取比例约为 6.9%。Open access: the journal is hybrid open access, allowing authors to publish under the subscription model or as paid open access, with a gold open access proportion of about 6.9% in 2025.
• 收录与分区： 收录于科学引文索引扩展版（SCIE）、Medline、PubMed、Scopus 与 Embase，2026 年中科院分区为医学三区、老年医学四区。Indexing and ranking: indexed in the Science Citation Index Expanded (SCIE), Medline, PubMed, Scopus and Embase, and classified in the third quartile of medicine and fourth quartile of geriatrics and gerontology under the 2026 Chinese Academy of Sciences scheme.